Pharmacogenomics (PGx) Cancer Panel

This panel evaluates 13 genes associated with response to cancer chemotherapeutics and associated supportive care medications. These include antiemetics, antifungals, antineoplastics, fluoropyrimidines, immunosuppressants, platelet-stimulating agents, proton pump inhibitors, and uric acid inhibitors. Results from this test may help in predicting treatment efficacy and risk of side effects for these drugs. Any information provided for drugs listed under "Limited Evidence Drug-Gene Associations" is provided for informational use only. For sections titled “Limited Evidence Drug-Gene Associations,” no interpretation of expected drug response is provided due to a lack of sufficient evidence and/or available guidelines.